Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Interpace Diagnostics (IDXG) Prices 12.5M Share Common Offering at $1.10/Sh
-
Interpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants
-
Interpace Diagnostics (IDXG) Converts All Remaining Long-Term Secured Outstanding Debt into Common Stock
-
Interpace Diagnostics Eliminates Long Term Secured Debt
-
Interpace Diagnostics (IDXG) Enters Agreement to Restructure Debt and Terminate Royalty and Milestone Obligations
-
Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations
-
Interpace Diagnostics Announces Closing of $3.9 Million Public Offering
-
Interpace Diagnostics (IDXG) Prices 1.2M Shares at $3
-
Interpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million
-
Interpace Diagnostics (IDXG) Plans Public Offering of Common Stock
-
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
-
Interpace Diagnostics (IDXG) Enters $4M Common Stock Securities Purchase Agreement
-
Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock
-
Interpace Diagnostics (IDXG) to Offer 855K Common Shares and Warrants
-
Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock
-
Interpace Diagnostics (IDXG) Discloses Private Placement of 375K Shares at $6.75/Share
-
Interpace Diagnostics (IDXG) Enters Agreement with a Single Investor to purchase 2M Shares of Common Stock at $0.53 Per Share
-
Interpace Diagnostics Announces $1.9 Million Registered Direct Offering of Common Stock
-
Interpace Diagnostics (IDXG) Reports $2.11M Registered Direct Offering of Common Stock

